# US 2023/0272004 A1 · Ramp tag for insulin overexpression and method for manufacturing insulin using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0272004 A1
- Document ID: US20230272004A1
- Status: Published application
- Kind: A1
- Application number: 17/418,746
- Filed: 2019-12-27
- Published: 2023-08-31
- Earliest claimed: 2018-12-31
- Assignees: Polus LLC
- Applicants: Polus Inc.
- Inventors: Jinhwan KIM; Hyoung An CHOI; Sang Yeon LEE
- Web page: https://patentgrep.com/patent/US20230272004A1

## CPC

- C07K 7/06: having 5 to 11 amino acids
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/62: Insulins
- C07K 2319/00: Fusion polypeptide
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- C07K 2319/21: containing a His-tag
- C07K 2319/35: containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to a ramp tag for insulin overexpression represented by an amino acid sequence of RGSX1GGX2R (wherein, X1 means any amino acids in the number of 0-8, and X2 means S or T) and a method for manufacturing insulin, in which the ramp tag is applied, and when the ramp tag according to the present invention is used, in the process of manufacturing recombinant proteins, without changing the ORF sequence, such as the codon optimization method, translation efficiency of insulin is increased, thereby providing the effect of remarkably increasing the expression amount of insulin.

## Claims

### Claim 1

A ramp tag for insulin overexpression represented by a following amino acid sequence: RGSX1GGX2R,
wherein, X1 represents 0-8 arbitrary amino acids and X2 represents S or T.

### Claim 2 (depends on 1)

The ramp tag according to claim 1, wherein the ramp tag is represented by an amino acid sequence selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 12, SEQ ID NO: 19, and SEQ ID NO: 24 to SEQ ID NO: 31.

### Claim 3

A ramp tag represented by an amino acid sequence selected from the group consisting of SEQ ID NOS: 1 to 4, SEQ ID NOS: 6 to 8, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NOS: 13 to 18, and SEQ ID NOS: 20 to 23.

### Claim 4 (depends on 1)

A nucleic acid encoding the ramp tag according to claim 1.

### Claim 5 (depends on 4)

The nucleic acid according to claim 4, wherein the nucleic acid is represented by a nucleic acid sequence selected from the group consisting of SEQ ID NO: 22 to SEQ ID NO: 42.

### Claim 6 (depends on 4)

An gene construct comprising the nucleic acid according to claim 4 and a nucleic acid encoding insulin or an insulin precursor.

### Claim 7 (depends on 6)

The gene construct according to claim 6, further comprising a nucleic acid encoding a tag other than the ramp tag and/or a nucleic acid encoding a fusion protein.

### Claim 8 (depends on 7)

The gene construct according to claim 7, wherein the tag other than the ramp tag is one or more selected from the group consisting of a His tag, HAK tag, T7 tag, S-tag, Flag-tag, HA-tag, V5 epitope, PelB, and Xpress epitope.

### Claim 9 (depends on 7)

The gene construct according to claim 7, wherein the fusion protein is one or more selected from the group consisting of COMP, GST, MBP, NusA, CBP, GFP, Thioredoxin, Mistic, Sumo, and DSB.

### Claim 10 (depends on 6)

The gene construct according to claim 6, wherein the insulin precursor is an insulin glargine precursor, an insulin aspart precursor, or an insulin lispro precursor.

### Claim 11 (depends on 6)

A recombinant vector comprising the gene construct according to claim 6.

### Claim 12 (depends on 6)

A recombinant cell comprising the gene construct according to claim 6.

### Claim 13 (depends on 12)

The recombinant cell according to claim 12, wherein the recombinant cell is configured such that the gene construct is introduced into a host cell selected from the group consisting of Escherichia coli, yeast, a Chinese hamster ovary cell (CHO cell), and a human cell line.

### Claim 14 (depends on 12)

A method of manufacturing insulin or an insulin precursor comprising:
(a) expressing insulin or an insulin precursor by culturing the recombinant cell according to claim 12; and
(b) recovering the expressed insulin or insulin precursor.
